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Abstract
The intercalation of the anions of diclofenac (Dic), naproxen (Nap), and valproic acid (Val) into three
hydroxy double salts (HDSs) has been explored in this work. Experiments were performed with
[Co1.2Zn3.8(OH)8](NO3)2·2H2O (CoZn-NO3), [Ni2Zn3(OH)8](NO3)2·2H2O (NiZn-NO3) and
[Zn5(OH)8](NO3)2·2H2O (Zn-NO3). It proved possible to intercalate diclofenac and naproxen into all
three HDSs. In contrast, Val could be intercalated into CoZn-NO3 but when it was reacted with Zn-
NO3 the HDS structure was destroyed, and the product comprised ZnO. Successful intercalation was
verified by X-ray diffraction, IR spectroscopy, and elemental microanalysis. Molecular dynamics (MD)
simulations showed the Dic and Nap ions to arrange themselves in an “X” shape in the interlayer
space, forming a bilayer. Val was found to adopt a position with its aliphatic groups parallel to the
HDS layer, again in a bilayer. In situ time resolved X-ray diffraction experiments revealed that
intercalation of Dic and Nap into CoZn-NO3 and Zn-NO3 is mechanistically complex, with a number of
intermediate phases observed. In contrast, the intercalation of all three guests into NiZn-NO3 and of
Val into CoZn-NO3 are simple one step reactions proceeding directly from the starting material to
product. The HDS-drug composites were found to have sustained release profiles.
1. Introduction
Layered metal hydroxides (LMHs) are a broad family of materials which have much potential in the
delivery of biologically active species. Two commonly occurring types of LMH are hydroxy double
salts (HDSs) and layered double hydroxides (LDHs). These have the same key structural features of
positively charged layers and charge-balancing anions located in the interlayer region, but they differ
in their layer compositions. LDHs contain a mixture of trivalent and mono or divalent metal
cations,1–4 while HDSs contain only divalent metal cations.5–7 The generic formula of an HDS is
2[(M2+x-1Me2+x)(OH)3(1-y)] Xn-(1+3y)/n·zH2O. M and Me are divalent metal ions such Zn2+, Cu2+, Ni2+, or
Co2+,8,9 and X is an anion such as Cl-, NO3-, or CO32-.9,10 The latter can be replaced, through an ion
exchange route, with a variety of inorganic and organic anions.11–14
LDHs have attracted the interest of many researchers for their potential as drug delivery systems.
They have been widely explored in vitro and in vivo for drug delivery and LDHs loaded with active
pharmaceutical ingredients (APIs) have shown improved properties over the free drugs in terms of
solubility, absorption, bioavailability and cellular uptake.15–22 However, much less attention has been
paid to HDSs in general and specifically to their potential as delivery systems. The few studies which
have been reported suggest that HDSs may have improved properties than LDHs in this regard. HDSs
have been intercalated with mefenamate, indole-3-acetate, 4-biphenylacetate, 4-(2,4-
dichlorophenoxy) butyrate and 2-(3-chlorophenoxy) propionate and in all cases the guests were
released from the HDS hosts over a prolonged period of time, with slower release than observed
with LDHs.7,23,24
In this work, a range of carboxylic acid drugs were explored. These can easily form anions suitable
for intercalation. The anti-inflammatory, analgesic, and antipyretic drugs diclofenac (Dic) and
naproxen (Nap), together with the anticonvulsant and mood stabilizing active ingredient valproic
acid (Val), were selected for investigation. The structures of these drugs are given in Figure 1.
Figure 1: The chemical structures of Dic, Nap and Val .
These guests were incorporated into a range of Zn-containing HDSs, and the resultant intercalates
fully characterised. An in situ X-ray diffraction study was performed to investigate the intercalation
mechanisms and kinetics. Molecular dynamics simulations were undertaken to aid interpretation of
the diffraction data. Finally, the release of the drugs was studied in simulated physiological
conditions.
2. Experimental section
32.1 Synthesis
2.1.1 Materials
Zinc oxide, zinc chloride, zinc nitrate hexahydrate, cobalt (II) nitrate hexahydrate, and nickel (II)
nitrate hexahydrate were supplied by Fisher Scientific; 99 %. Diclofenac sodium (Dic) was sourced
from Cambridge Bioscience, and naproxen sodium (Nap) and valproate sodium (Val) were purchased
from Sigma-Aldrich.
2.1.2 HDS synthesis
The HDSs were synthesised using methods reported previously.10 The reaction mixtures detailed in
Table 1 were prepared in water and stirred for 7 days at room temperature. The solid products were
isolated by vacuum filtration, washed with copious amounts of deionised water and a small amount
of acetone, then dried in an oven for 4 hours at 40 °C.
Table 1: Summary of HDS synthesis conditions.
HDS Starting materials Volume (ml)
[Zn5(OH)8](NO3)2·yH2O
[Zn-NO3]
ZnO (4.2 g) + Zn(NO3)2·6H2O (24.1 g) 60
[Zn5(OH)8]Cl2·yH2O
[Zn-Cl]
ZnO (3.0 g) and ZnCl2 (7.26 g) 18
[Zn3Ni2(OH)8](NO3)2·yH2O
[NiZn-NO3]
ZnO (3.0 g) + Ni(NO3)2·6H2O (8.73 g) 18
[Zn3.8Co1.2(OH)8](NO3)2·yH2O
[CoZn-NO3]
ZnO (3.0 g) + Co(NO3)2·6H2O (8.73 g) 18
2.1.3 Intercalation reactions
Intercalation was achieved by combining 0.4 mmol of an HDS with a 4-fold excess of the guest
anions. 10 ml of deionised water was added to the solid materials, and the mixture stirred at 60 °C
for 3 days. The solid products were filtered under vacuum, washed with deionised water, and dried.
2.1.4 Guest recovery
The ability to recover the guest ions intact after intercalation was investigated in selected cases by
reacting ca. 50 mg of the intercalate with approximately 100 mg of Na2CO3 in D2O overnight at 80 °C.
The resultant suspension was filtered and the filtrate analysed by 1H NMR.
42.2 Characterisation
2.2.1 X-ray diffraction
X-ray diffraction (XRD) was performed using a Philips PW1830 instrument operating at 40 kV and 25
mA with Cu Kα radiation (λ = 1.5418 Å). Samples were finely ground and mounted on aluminium 
plates for measurement. Patterns were recorded over the 2θ range from 2 – 20°. Diffracted intensity 
from the sample holder did not interfere with sample characterisation.
2.2.2 IR spectroscopy
IR spectra were recorded on a Perkin-Elmer Spectrum 100 instrument. Data were recorded from
4000 to 650 cm-1 at a resolution of 2 cm-1.
2.2.3 NMR spectroscopy
1H NMR spectra were obtained on a Bruker Avance-400 instrument at ambient temperature (1H
frequency: 400 MHz). Samples were dissolved in D2O prior to measurement.
2.2.4 Elemental analysis
C, H, and N contents were determined using the quantitative combustion technique on a Carlo Erba
CE1108 elemental analyser.
2.2.5 In situ X-ray diffraction
The first series of in situ XRD measurements was performed on Beamline F3 of the DORIS
synchrotron at the Deutsches Elektronen-Synchrotron (DESY), Hamburg, Germany. The energy-
dispersive X-ray diffraction (EDXRD) technique was employed here. Further in situ XRD experiments
were undertaken at the Diamond Light Source, using Beamline I12 and the Oxford-Diamond In Situ
Cell (ODISC). These used an angle-dispersive modality, with an X-ray beam monochromated at ca.
0.23 Å and a Pixium area detector. Full details of the equipment used is reported elsewhere.25,26
Both at DESY and Diamond, 0.4 mmol of the desired HDS was mixed with 1.6 mmol of the guest ion
in 10 ml of deionised water and heated to the desired temperature. Diffraction patterns were
recorded every 60 seconds (DESY) or 4 seconds (Diamond) until no further changes in these were
observed. Data analysis was performed by integrating reflections of interest using the F3Tool
software (DESY), or by employing Fit2D27 to convert the as-collected images into one-dimensional
patterns, subtracting the background, and applying in-house tools to integrate the reflections of
interest (Diamond). Integrated data were subsequently probed using the Avrami–Erofe’ev model;28–
31; more details are given in the results section.
52.2.6 Modelling
Models of the Zn-NO3 derived HDS systems were built in the space group C2/m, using the structure
previously reported by Stahlin and Oswald.32 In this symmetry, β = 93.28°, a = 19.48 Å, b = 6.238 Å 
and c = 5.517 Å. All molecular dynamics (MD) simulations were carried out using the Materials
Studio v5.5 software package (Accelrys Software Inc).33 Temperature and pressure control were
implemented using the Andersen34 and the Berendsen35 methods respectively. Coulombic
interactions were computed by the Ewald summation technique 36 and van der Waals interactions
using a “spline-cut off” method. The simulations were performed with the aid of the LDHFF force
field.37 The time-step was set to be 1 fs, which is deemed to be suitable for the characterisation of
thermal motion,38 and the simulation time at 5 ns. For MD work, both water bound to tetrahedral Zn
and free interlayer water were included in the simulation, with models of the final products isolated
ex situ constructed using the formulae [Zn5(OH)8(Val)2·3H2O]4, [Zn5(OH)8(Nap)2·3H2O]2 and
[Zn5(OH)8(Dic)2·4H2O]2. The interactions between the layers and free interlayer water are known to
be small, and so the differences between the amounts of water observed experimentally and those
approximated in this approach should not lead to the introduction of any significant errors. For MD
work on the intermediate phases observed in situ, the same model as above was used for Dic. In the
Nap case free water molecules caused the simulation to fail, and thus only water bound to
tetrahedral Zn was included (formula: [Zn5(OH)8(Nap)2·2H2O]2)
3. Results and Discussion
3.1 Intercalation into CoZn-NO3
It proved facile to intercalate the APIs into the CoZn-NO3 HDS through anion exchange. XRD patterns
of the drug intercalates of CoZn-NO3 are given in Figure 2. The reaction products show no
characteristic basal reflections of the starting material, and a shift of the h00 basal reflections to
lower angles; this corresponds to an increase in interlayer distance consistent with the incorporation
of a larger anion (see Table 2). The interlayer spacings seen are in good agreement with previous
results for LDHs: Khan et al. recorded d-spacings of 22.3 Å for Dic, 21.5 Å for Nap and 18.7 Å for Val
.39 All the diffraction patterns illustrate peak broadening, indicative of stacking defects.
6Figure 2: XRD patterns of CoZn–NO3 and its intercalates.
Elemental analyses of the intercalation compounds (Table 2) indicated complete replacement of
nitrate with the API guests had been achieved.
Table 2: Interlayer spacings and chemical formulae of the various HDS-drug composites prepared.
a In some cases, two intercalate phases with different interlayer spacings were observed. The latter d-spacing is that of the
minority phase.
The intercalation compounds were also characterised by IR spectroscopy (see Figure 3). The
spectrum of CoZn-NO3 shows typical features of an HDS. A broad peak centred at around 3250 cm-1
ID d200 (Å) Formula
Elemental analysis (%)
Obsd (calcd)
CoZn-NO3 9.7 [Co1.2Zn3.8(OH)8](NO3)2·2H2O -
CoZn-Val 19.4 [Co1.2Zn3.8(OH)8](C8H15O2)2·2.5H2O
C 24.46 (24.43)
H 5.55 (5.51)
N 0.0 (0.0)
CoZn-Dic 22.3 [Co1.2Zn3.8(OH)8](C14H10Cl2NO2)1.6(CO3)0.2·2H2O
C 28.25 (27.83)
H 2.77 (2.89)
N 1.44 (2.30)
CoZn-Nap 24.1 [Co1.2Zn3.8(OH)8](C14H13O3)1.8(CO3)0.1·3.4H2O
C 32.21 (32.49)
H 4.12 (4.12)
N 0.0 (0.0)
NiZn-NO3 9.7 Ni2Zn3(OH)8(NO3)2·2H2O -
NiZn-Dic 21.2/15.6a [Ni2Zn3(OH)8](C14H10Cl2NO2)1.65(NO3)0.35·2H2O
C 27.91 (27.90)
H 2.42 (2.89)
N 3.31 (2.82)
NiZn-Nap 24.2 [Ni2Zn3(OH)8](C14H13O3)1.72 (CO3)0.14·2.7H2O
C 32.21 (32.29)
H 4.03 (4.00)
N 0.0 (0.0)
Zn-NO3 9.7 [Zn5(OH)8](NO3)2·2H2O -
Zn-Dic 22.3/19.5a [Zn5(OH)8](C14H10Cl2NO2)2(C14H11Cl2NO2)0. 4·2H2O
C 33.68 (33.42)
H 1.67 (3.01)
N 3.05 (2.78)
Zn-Nap 23.6/20.3a [Zn5(OH)8](C14H13O3)2·2H2O
C 34.87 (35.12)
H 3.90 (4.00)
N 0.0 (0.0)
7corresponds to H-bonded OH groups of the HDS layers. The δ-vibration of the interlayer water 
molecules is located at 1636 cm-1, the NO3- vibrations at ca. 1373 cm-1, and Zn–O vibrations from the
HDS layers are visible below 1000 cm-1. The spectrum of Dic (Figure 3) displays distinctive symmetric
and asymmetric carboxylate bands at 1397 and 1572 cm-1 respectively. An additional peak at 746
cm-1 corresponds to the C-Cl group. The IR spectrum from the CoZn-Dic intercalation compound is a
combination of those from the HDS and API, containing a broad OH absorption band at around 3400
cm-1, distinctive carboxylate vibrations at 1580 and 1397 cm-1, and a C-Cl vibration at 746 cm-1. There
is no visible peak at 1373 cm-1 for the intercalate, implying that the nitrate ions have been displaced
from the structure. The shift in the position of the asymmetric carboxylate band from 1572 cm-1 in
Dic to 1580 cm-1 in CoZn-Dic may be attributed to electrostatic interactions between the COO-
groups of the anions and the hydroxide layers.
The IR spectra for the other CoZn-NO3 intercalates also show the disappearance of the nitrate
absorption and the presence of characteristic bands from the guest ions (see Supplementary
Information, Figure S1).
Figure 3: IR spectra of CoZn-NO3, CoZn-Dic and Dic.
3.2 Intercalation into other HDSs
Intercalation into two further HDSs, Zn-NO3 and NiZn-NO3, was also explored. Attempts to react Val
with Zn-NO3 were unsuccessful, yielding ZnO as the solid reaction product (see Figure S2). For the
other materials, the XRD and elemental analysis data (Table 2 and Figure S2) show the intercalation
compounds to be largely analogous to those prepared from CoZn-NO3. In the diffraction patterns of
Zn-Dic, NiZn-Dic and the Zn-Nap material it appears that there are two intercalate phases with
8different d-spacings (see Figure S2 and Table 2). These may be ascribed to two different orientations
of the guest ions. IR spectroscopy (Figure S3) additionally demonstrated successful intercalation of
the Dic and Nap anions into all the HDSs.
3.3 Guest recovery
The CoZn-Dic, CoZn-Nap and CoZn-Val intercalates were reacted with Na2CO3 in D2O, and NMR
spectra recorded of the filtrates from these reactions. The spectra after deintercalation are observed
to be identical to those of solutions of the pure APIs, confirming that the structural integrity of these
drug molecules is retained. Exemplar data are given in Figure S4.
3.4 Guest orientation
Molecular dynamics (MD) simulations were performed to explore the orientations of the guests in
the interlayer space. These were performed using the reported structure for Zn-NO3,32 since no
crystal structures are known for the mixed-metal systems. For Val, simulations indicate a bilayer of
ions is formed between the layers, as shown in Figure 4(a). The model gives an interlayer spacing of
19.1 ± 0.1 Å. This result is in good agreement with the experimental value (19.4 Å), with the small
difference between experimental and simulation being well within the range of deviations reported
in previous LDH modelling studies (very little modelling work has been done using HDSs).40–44 The Val
ions adopt a perpendicular position in the interlayer regions, with their carboxylate groups facing the
HDS layer and the aliphatic chains towards the centre. The simulation shows that H-bonding occurs
between the COO- group of Val, water and the HDS layer.
Simulations with Nap ions also suggest a bilayer arrangement of guests between the HDS layers,
with a d-spacing of 24.0 ± 0.1 Å (Figure 4(b)), in very good agreement with the experimental value of
23.6 – 24.2 Å seen for the major intercalate phase (for Zn-Nap, a second API-loaded phase with a
lower d-spacing was observed). The Nap ions form an “X” shape in three dimensions. This keeps the
hydrophobic regions of the molecules close together in the centre of the interlayer, and the
hydrophilic regions close to the tetrahedral Zn2+ and facing the positively charged layers. Dic ions are
similarly predicted to form an “X” shape (Figure 4(c)), leading to a simulated interlayer spacing of
22.0 ± 0.3 Å (cf. 21.2 – 22.3 Å observed experimentally). H-bonds are also calculated to be present in
the Nap and Dic MD simulations.
9(a) (b) (c)
Figure 4: MD results (a) Val; (b) Nap; and, (c) Dic. H-Bonds are shown in blue and the tetrahedral Zn2+ sites are
highlighted in yellow.
3.5 In situ diffraction
3.5.1 Intercalation of Val
Data for CoZn-NO3 are given in Figure 5(a). The reaction at 80 °C was seen to be a one stage process,
proceeding directly from the starting material to the product. The intercalate exhibits virtually the
same d-spacing in situ (19.8) as seen in laboratory syntheses (19.4 Å). No crystalline intermediate
phases were visible in the diffraction data.
(a) (b) (c)
Figure 5: In situ XRD data for the intercalation of Val into CoZn-NO3 at 80 °C. (a) Contour plot of the raw data;
(b) extent of reaction vs. time data showing the changes in intensity of the host () and product () 200
reflections; and, (c) a Sharp-Hancock plot for the product 200 reflection.
The intensities of the 200 reflections of the CoZn-NO3 and CoZn-Val materials were integrated, and
converted into extent of reaction, α. This is essentially a normalisation processes: α = Ihkl(t)/Ihkl(max),
where Ihkl(t) is the intensity of a reflection hkl at time t, and Ihkl (max) is the maximum intensity of
that reflection. A plot of α vs. time is illustrated in Figure 5(b). The curves of the starting material and
product cross at α ≈ 0.45, which indicates a one stage transformation. This crossing point shows that 
the diffracted intensity lost from the starting material is matched by intensity gained by the product,
and therefore the intercalation reaction has not passed through an intermediate phases (if there
were an intermediate stage, the starting material and product curves should cross close to α ≈ 0).  
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The Avrami–Erofe’ev model, which has been very widely used with intercalation processes,45–47 was
applied to the data for Val intercalation. This states:
α = 1 − e(୩୲)౤
where α is the extent of reaction, t is the time, k the rate constant, and n an exponent which can be 
used to infer details of the reaction mechanism.10 A Sharp-Hancock plot of ln(-ln(1 - α)) vs. ln t can be
conveniently used to calculate n and k (Figure 5(c)). The plot in Figure 5(c) is linear, indicating that
the reaction proceeds via a consistent mechanism over almost the entire course of the reaction, and
that the Avrami–Erofe’ev model is suitable to describe this system. The reaction exponent n is
observed to be ca. 1 (Table 3). This suggests that the reaction is a nucleation growth process, with
instantaneous nucleation followed by two dimensional diffusion control. The layer edges are the
nucleation sites, and ‘‘instantaneous’’ nucleation suggests that all these are saturated with guest
ions at the start of the reaction. Two-dimensional diffusion control indicates that, once a pair of
layers has been prised apart, the movement of the new guest ions into the interlayer space is facile:
thus, diffusion control operates thereafter.10
Table 3: The results of Avrami-Erofe’ev analyses of the intercalation processes.
3.5.2 Intercalation of Dic
This reaction was studied at 80 °C for all three HDSs. Plots of the raw data obtained on DESY are
depicted in Figure 6.
ID T / °C n k (10-3 s-1) Notes
CoZn-Val 80 1.04 2.96
CoZn-Dic 80 Avrami-Erofe’ev kinetics not applicable
NiZn-Dic
75 1.01 1.03
Ea ≈28.7 kJ mol
-1
80 1.00 1.18
Zn-Dic 80 Avrami-Erofe’ev kinetics not applicable
CoZn-Nap 80 Avrami-Erofe’ev kinetics not applicable
NiZn-Nap
60 0.98 1.22
Ea ≈ 33.4 kJ mol
-170 0.98 1.63
75 1.19 2.09
80 Avrami-Erofe’ev kinetics not applicable
Zn-Nap 80 Avrami-Erofe’ev kinetics not applicable
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(a) (b) (c)
Figure 6: Plots of the raw data for intercalation of Dic into (a) NiZn-NO3; (b) CoZn-NO3; and, (c) Zn-NO3 at 80 °C.
Dic intercalation into NiZn-NO3 appears to be a straightforward process: the reaction proceeds
directly from the starting material to the product, which at 24.3 Å has a d-spacing somewhat higher
that observed in laboratory synthesis (presumably due to increased hydration levels). This is
confirmed by the α vs. time plots of host and product crossing at ca. 0.5 (Figure S5(a)). An Avrami-
Erofe’ev analysis yields n ≈ 1 (Figure S5(b)), indicating a mechanism of 2D diffusion control following 
instantaneous nucleation as discussed above. Performing the reaction at two different temperatures
allowed the activation energy to be estimated at ca. 28.7 kJ mol-1.
The CoZn-NO3 and Zn-NO3 data are more complex. The d-spacing of the final product in the in situ
experiments is 16.3 – 16.5 Å, much lower than the 22.3 Å observed ex situ. Further, in both Figure
6(b) and (c), a reflection at around 9.16 – 9.30 Å is observed to grow in at the same time as the
product first appears. This was initially thought to be an artefact, and to verify this hypothesis
further experiments were performed with Zn-NO3 on Beamline I12 of the Diamond Light Source,
which has much better resolution. The resultant data are given in Figure S6: they verify those
obtained on DESY, clearly showing the reflection at ca. 9.2 Å to be genuine and not an experimental
artefact. MD simulations were carried out to model this phase and predicted a system with Dic ions
intercalated in a horizontal arrangement. This gave a d-spacing of 9.28 Å, close to the experimental
value. Thus, it seems that at the start of the intercalation process some of the Dic ions intercalate
vertically between the layers, while others intercalate horizontally and subsequently rearrange
themselves.
To understand why the final product seen in situ has a 200 reflection with a lower d-spacing than
observed ex situ, the reaction was run at 80 °C and the solid recovered by rapid filtration after 80
min. The XRD pattern of the quenched product (Figure S7) shows a virtually identical interlayer
spacing to that observed in situ (15.6 Å). The quenched product was returned to the Dic solution and
left to stir at 80 °C for approximately 10 h further. The XRD pattern of the material recovered shows
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a very intense reflection at 20.5 Å, while the phase at 15.6 Å has almost vanished. Thus, we can
conclude that the 16.3 Å phase seen in situ is a long-lived intermediate en route to the final product
(d200 = 19.5 – 22.5 Å). CHN analysis of the material recovered after 80 min shows that only 65 % of
the initial NO3- ions had been replaced; further reaction leads to replacement of the remaining ions
to yield a fully intercalated product with a higher d-spacing (Table 2). MD simulations (Figure S8)
indicated that the 15.6 Å phase this contains the guest ions arranged in a perpendicular monolayer.
The Dic carboxylate groups are close to the tetrahedral Zn2+ ions. This arrangement is thought to
become unstable when the number of Dic ions in the interlayer region increases and the amount of
NO3- ions declines. As a result, at a critical Dic content the ions rearrange themselves to give a phase
with an interlayer spacing of 19.5 – 22.5 Å.
During the intercalation of Dic into Zn-NO3 and CoZn-NO3, we observed an initial drop in the
intensity of the starting material 200 reflection, followed by a subsequent increase. This was
observed in four independent experiments, both at Diamond (Figure S7) and DESY, and thus is
believed to be a genuine feature of the reaction rather than an artefact arising from, for instance, a
failure in stirring. We thus postulated that an additional intermediate phase might be forming, with
a d-spacing very similar to that of the starting material.
To confirm this suggestion, experiments were performed with the HDS [Zn5(OH)8]Cl2·yH2O (Zn-Cl)
which has a different initial interlayer spacing (7.8 Å) but otherwise behaves similarly to Zn-NO3.
Quenching reactions were conducted under the same conditions as used for in situ studies, and the
results are shown in Figure S9. The XRD patterns show clear reflections at 9.3 and 9.9 Å, suggesting
that the in situ phenomenon seen during the intercalation of Dic into Zn-NO3 is caused by an
intermediate that has a d-spacing of 9.8 Å.
Plots of α vs. time for Dic intercalation into CoZn-NO3 and Zn-NO3 are depicted in Figure S10.
Although it appears at first sight that the curves from the starting material and the 16 Å intercalate
cross at around α = 0.5, the situation is in fact more complex because of the presence of an 
intermediate with identical d-spacing to the starting material. Attempts were made to fit the
Avrami-Erofe’ev model to the data, but these were inconclusive: the resultant Sharp-Hancock plots
were decidedly non-linear, indicating a complex reaction which does not proceed via a consistent
mechanism throughout. This is perhaps not surprising given the number of different phases
identified on the reaction coordinate.
3.5.3 Intercalation of Nap
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In situ diffraction data for the intercalation of Nap are given in Figure 7.
(a) (b)
Figure 7: Plots of the raw data for intercalation of Nap into (a) NiZn-NO3; and, (b) CoZn-NO3 at 80 °C.
As for Dic, the process of Nap intercalation into NiZn-NO3 is found to be a simple one-step process
going directly from the starting material to the product. The host and product α vs. time curves cross
at α ≈ 0.5 (see Figure S11). The product 200 reflection arises at around 24.6 Å (400: 12.4 Å, 600: 8.3
Å). The interlayer spacing observed in situ is thus very similar to that seen ex situ (24.2 Å). At 80 °C,
the reaction appears not to follow Avrami kinetics, with highly non-linear Sharp-Hancock plots being
seen. At lower temperatures, the reaction is again observed to proceed directly to the product, but
linear Sharp-Hancock plots are produced and values for n and k may be extracted (Table 3). n is
found to be ca. 1, indicative of 2D diffusion control following instantaneous nucleation as observed
previously. The Arrhenius equation was used to estimate the kinetic energy; this was found to be
approximately 33.4 kJ mol-1, consistent with a nucleation-controlled reaction.
The intercalation of Nap into CoZn-NO3 at 80 °C (Figure 7(b)) shows that the final product observed
in situ has essentially the same interlayer spacing as seen ex situ (24.3 Å vs. 24.1 Å). Clear crystalline
intermediate phases are visible in the diffraction data, with three distinctive reflections that appear
and disappear synchronously. These are believed to be the 400 (14.4 / 13.5 Å) and 600 (9.4 Å)
reflections of two higher d-spacing intermediate phases (the 200 positions of these at 27 – 29 Å
placed them beyond the detection window). Repeating these experiments on Beamline I12 at
Diamond (Figure S12) identified the same features, with some additional reflections corresponding
to these intermediate phases resolvable in the patterns. α vs t curves for this system are given in 
Figure 8. The reflections from CoZn-NO3 and CoZn-Nap cross at α ≈ 0, consistent with the 
observation of an intermediate. The starting material vs intermediate curves cross at α ≈ 0.5, as do 
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the intermediate vs product curves. This indicates a two stage transformation. The results of MD
simulations are presented in Figure S13. The higher d-spacing phases are found to arise from the
Nap ions being arranged in a perpendicular bilayer, with a d-spacing of 28.0 Å. This arrangement is
presumably unstable, and thus as the reaction continues the Nap ions rearrange themselves to give
a phase with an interlayer spacing of 24.3 Å.
Figure 8: α vs. time plot for the intercalation of Nap into CoZn-NO3 at 80 °C. Intermediate 1 refers to the 400
reflection at 14.4 Å and intermediate 2 to that at 13.5 Å.
The Sharp-Hancock plot for CoZn-Nap formation was decidedly non-linear, indicating that simple
Avrami kinetics are not sophisticated enough to describe this complex system.
The intercalation of Nap into Zn-NO3 produces two product phases of different d-spacings in the
laboratory syntheses. This same phenomenon is seen in the time-resolved data (Figure 9). A phase
first grows in at 20.8 Å before a second product phase appears at 24.0 Å. These d-spacings are very
similar to those seen ex situ (Table 2). Plotting the extent of reaction vs. time (Figure S14) suggests
that the 20.8 Å phase exists in equilibrium with the 24.0 Å phase; although the integrated intensity
of the former declines very slightly during the course of intercalation, it then appears to level off.
There is a very transient and poorly crystalline intermediate phase which forms at 9.2 Å. This phase
is believed on the basis of MD simulations to have the Nap ions intercalated horizontally, analogous
to the Dic system discussed above. The data obtained on Diamond (Figure 9(b)) also show another,
very poorly crystalline, intermediate phase present with a 002 reflection at 21.5 Å.
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(a) (b)
Figure 9: Time resolved XRD data obtained for the intercalation of Nap into Zn-NO3 on (a) DESY and (b)
Diamond at 80 °C, showing the possible presence of a transient and low crystallinity intermediate phases
(labelled in red/orange). The peak marked * is an escape peak from the Ge detector.
The Sharp–Hancock plot for the 24.0 Å product was non-linear, indicating the non-applicability of
Avrami kinetics here. The 20.8 Å phase produced a linear plot but the exponent value was not
consistent with any of the possible mechanisms of reaction, and thus again it is thought Avrami
kinetics cannot be applied. The simulated structure of the 24.0 Å phase is discussed above; the other
phases at 20.8 and 21.5 Å are believed to be similar, but with reduced hydration levels.
3.6 Drug release
A drug release study was carried out on selected systems in phosphate buffered saline (PBS; pH 7.4)
to explore the potential of the HDS systems for drug delivery. Dic release (see Figure 10(a)) was
faster from Zn-NO3 than from the HDSs containing a mixture of divalent metals (CoZn-NO3 and NiZn-
NO3). The drug was released fully within 6 h from Zn-Dic, while a maximum of around 75 % release
was observed from NiZn-Dic after this time, and only 85 % release was reached after 24 h (Figure
10(a)). Release from all the HDSs is initially rapid, followed by a slower and more sustained release
phase. This two-stage release behaviour has previously been reported from LDH and HDS systems
with various drugs, including NSAIDs.48–52 Similar Dic release profiles have been seen for both HDSs
and LDHs.50,53,54 The metal composition of the layers clearly has an influence on the release rates
obtained.
The Nap release profile from CoZn-Nap is given in Figure 10(b); the full drug loading was released
within 5 h. Nap is thus released more rapidly than Dic from the CoZn system, which could be
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explained by the higher solubility of the former.55,56 The release profiles seen here are more
sustained than those previously observed. LDHs in general have been shown to release their drug
cargo more quickly than HDSs and here Nap release proceeds more slowly than has been reported
from both LDHs and HDSs, where complete release in less than 100 min was seen.20,57–59
(a) (b)
Figure 10: In vitro release of (a) Dic from Zn-Dic, NiZn-Dic and CoZn-Dic; (b) Nap from CoZn-Nap.
Trial release experiments were also carried out in conditions that mimic passage through the human
gastrointestinal tract (2h in a pH 1 medium, followed by transfer to a pH 6.8 PBS; see Figure S15). Zn-
Dic released only 2 % of its drug loading in the acidic media, but upon raising the pH to 6.8 this
process was accelerated and most of the drug loading freed within 9 h. Release from CoZn-Dic was
slower, and was complete after around 21 h. Again, very little release was seen at pH 1. Release
from both Zn-Dic and CoZn-Dic was slower at pH 6.8 than 7.4; such a positive correlation between
the rate of release from layered systems and pH has been reported previously.60,61 On the basis of
the data reported herein, HDSs seem to have promise for sustained release. Further, the release
profiles observed suggest that loading the drug-loaded HDSs into capsules would give formulations
meeting the pharmacopeia requirements for intestinal drug targeting.62–64
4. Conclusions
The anions of diclofenac (Dic), naproxen (Nap), and valproic acid (Val) were intercalated into several
Zn-based hydroxy double salts (HDSs). The attempted intercalation of Val into [Zn5(OH)8](NO3)2·2H2O
(Zn-NO3) led to the destruction of the HDS layers to yield ZnO. In contrast, the presence of Co2+ in the
HDS appears to stabilise the layers and resulted in the successful intercalation of Val into
[Co1.2Zn3.2(OH)8](NO3)2·2H2O (CoZn-NO3). Molecular dynamics simulations suggested that the Dic and
Nap ions were arranged in an “X” shape, forming a bilayer arrangement in the interlayer space. Val
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was determined to adopt a position with its aliphatic groups parallel to the HDS layer, and again
form a bilayer.
In situ time resolved X-ray diffraction experiments showed that the intercalation of Dic and Nap into
CoZn-NO3 and Zn-NO3 proceeds by distinct intermediates, while their intercalation into NiZn-NO3 are
simple one step reactions proceeding directly from the starting material to product. The one-step
processes obeyed simple Avrami-type kinetics and were found to be nucleation-governed processes,
with instantaneous nucleation followed by 2D diffusion control. In contrast, where intermediates
were observed Avrami kinetics could not be applied. The d-spacings observed for the intermediates
were not consistent with staging processes, and molecular dynamics simulations suggested the
intermediate phases to be a result of reorientation of the drug anions between the layers and/or
varying hydration amounts. The HDS-drug composites were found to have sustained release profiles,
and comply with pharmacopeia requirements in this regard.
The presence of Ni and Co in some of the systems reported in this work comprises a hurdle to their
translation to the clinic. Although it is not believed that the materials reported here would be toxic
(the amounts of HDS/drug composites required would free quantities of Ni and Co well below LD50
values, even if they dissolved fully), in our future work we will develop a series of HDSs using the
most biocompatible metals possible.
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